Arcus Biosciences Inc
NYSE:RCUS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Arcus Biosciences Inc
NYSE:RCUS
|
US |
|
D
|
DiDi Global Inc
OTC:DIDIY
|
CN |
|
Synopsys Inc
MIL:1SNPS
|
US |
|
Sappi Ltd
F:SPI
|
ZA |
|
NEC Corp
TSE:6701
|
JP |
|
M
|
MFE-MEDIAFOREUROPE NV
MIL:MFEB
|
IT |
|
Brightspring Health Services Inc
NASDAQ:BTSG
|
US |
|
PICC Property and Casualty Co Ltd
HKEX:2328
|
CN |
|
California Resources Corp
NYSE:CRC
|
US |
|
China National Nuclear Power Co Ltd
SSE:601985
|
CN |
|
V
|
Vulcan Materials Co
SWB:VMC
|
US |
|
A
|
Akzo Nobel NV
OTC:AKZOF
|
NL |
|
Aviva PLC
OTC:AIVAF
|
UK |
|
Riber SA
PAR:ALRIB
|
FR |
|
EVI Industries Inc
F:2YE
|
US |
|
R
|
RWE AG
DUS:RWE
|
DE |
|
AXA SA
XETRA:AXA
|
FR |
|
Bayerische Motoren Werke AG
OTC:BMWYY
|
DE |
|
H
|
Home Depot Inc
LSE:0R1G
|
US |
|
C
|
Cisco Systems Inc
BMV:CSCO
|
US |
|
Juniper Networks Inc
NYSE:JNPR
|
US |
|
Talanx AG
OTC:TNXXF
|
DE |
|
C
|
Currys PLC
OTC:DSITF
|
UK |
|
Anglo American PLC
OTC:AAUKD
|
UK |
Bankruptcy Probability
Arcus Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Arcus Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Arcus Biosciences Inc
NYSE:RCUS
|
3.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
384.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
181.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
167B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
39.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Arcus Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Arcus Biosciences Inc has total debt of 99m USD. This includes both short-term (0 USD) and long-term (99m USD) debt.
You can find a full breakdown on its Balance Sheet.
